Discover 1,621 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,621
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Durham NC, Chapel Hill NC, Raleigh NC, Fayetteville NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Durham NC, Chapel Hill NC, Raleigh NC, Fayetteville NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
for
HIV-1-infection
Location: Durham NC, Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70
Code: NCT07596888
Phase1, Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Durham NC, Fairfax VA, New York NY, Nashville TN,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
for
Urinary Tract Infections
Location: Raleigh NC, Ocala FL, St Louis MO, Hialeah FL, Doral FL,
Sponsor: Locus Biosciences
Sex: Female
Age: 18 - 70+
Code: NCT05488340
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
for
Late-onset Pompe Disease
Location: Durham NC, Fairfax VA, St Louis MO, Irvine CA
Sponsor: Denali Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07354724
Phase1, Recruiting
Active & Responsive
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
for
Chondral Defect, Articular Cartilage Defect
Location: Durham NC, Charlottesville VA, Washington D.C. DC,
Sponsor: Vericel Corporation
Sex: All
Age: 17 - 65
Code: NCT06915233
Phase3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Durham NC, Cary NC, Raleigh NC, Roanoke VA, Salem VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Durham NC, Asheville NC, Augusta GA, Lexington KY,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase2, Recruiting
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: Durham NC, Winston-Salem NC, Richmond VA, Atlanta GA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase2, Recruiting
Active & ResponsiveNew
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib